TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3061717

Group type: EXPERIMENTAL
Intervention: Frusemide (40 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frusemide (40 mg) followed by standing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril administration in the supine position
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frusemide injection and standing
Number of subjects: 0
Study: 30620067

Group type: EXPERIMENTAL
Intervention: COST‐Africa BSc training programme
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: COST‐Africa trainees
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control hospitals
Number of subjects: 17
Study: 28089784

Group type: EXPERIMENTAL
Intervention: Pre-NST axillary node evaluation procedures (fine needle aspiration, core needle biopsy, sentinel node biopsy)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Post-NST sentinel node biopsy
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Post-NST axillary lymph node dissection (ALND)
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Post-NST axillary evaluation
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Post-NST clinical and radiologic staging
Number of subjects: 704
Study: 25809628

Group type: EXPERIMENTAL
Intervention: Methotrexate therapy and Black seed oil (80 mg/kg/day for one week after each methotrexate dose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Methotrexate therapy and placebo
Number of subjects: 40
Study: 24010577

Group type: EXPERIMENTAL
Intervention: 20 mg cobimetinib oral dose with high-fat meal
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 20 mg cobimetinib oral dose (tablets)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 20 mg rabeprazole daily for 5 days prior to cobimetinib administration
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 2 mg intravenous infusion of cobimetinib
Number of subjects: 53
Study: 21961644

Group type: EXPERIMENTAL
Intervention: Single intravenous dose of Co-Amoxiclav (Enhancin) at induction
Number of subjects: 126

Group type: COMPARATOR
Intervention: Five days oral course of Co-Amoxiclav postoperatively
Number of subjects: 126
Study: 19646778

Group type: EXPERIMENTAL
Intervention: Topical pimecrolimus applied twice daily for 5 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Observation sides of face (no treatment)
Number of subjects: 24
Study: 17576937

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg twice weekly
Number of subjects: 618

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 618
Study: 16260197

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg intravenously every 12 hours until delivery and 3 additional doses after delivery for pregnant women; 3 doses of 10 mg after delivery for puerperal women)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo (same schedule as dexamethasone)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 132
Study: 11904595

Group type: EXPERIMENTAL
Intervention: Lidocaine (1% instilled onto the Fallopian tubes)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 24
Study: 10588591

Group type: EXPERIMENTAL
Intervention: IL‐4R 1,500 microg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: IL‐4R 500 microg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 7782486

Group type: EXPERIMENTAL
Intervention: Lormetazepam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2179550

Group type: EXPERIMENTAL
Intervention: Cyclosporine (5 mg/kg)
Number of subjects: 92

Group type: COMPARATOR
Intervention: D-penicillamine (250 mg)
Number of subjects: 92
Study: 7191300

Group type: EXPERIMENTAL
Intervention: triamterene preparation 1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: triamterene preparation 2
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: triamterene preparation 3
Number of subjects: 6
Study: 31963636

Group type: EXPERIMENTAL
Intervention: Oral piercings
Number of subjects: 387
Study: 31591263

Group type: EXPERIMENTAL
Intervention: Omega-3 carboxylic acids (OM3-CA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 0
Study: 27611807

Group type: EXPERIMENTAL
Intervention: Long-term maintenance program after initial pulmonary rehabilitation (PR) for 3 years
Number of subjects: 143

Group type: COMPARATOR
Intervention: Standard monitoring program (Control Group)
Number of subjects: 143
Study: 26010890

Group type: EXPERIMENTAL
Intervention: Blended treatment (four face-to-face sessions and a smartphone application)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Full behavioural activation treatment (ten sessions)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Blended treatment
Number of subjects: 93

Group type: COMPARATOR
Intervention: Blended treatment vs Full treatment
Number of subjects: 93
Study: 23066879

Group type: EXPERIMENTAL
Intervention: Nordic walking (NW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual overground walking (OW)
Number of subjects: 0
Study: 21602713

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg
Number of subjects: 177

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 177
Study: 19052779

Group type: EXPERIMENTAL
Intervention: Outpatient cognitive behavioural treatment (CBT)
Number of subjects: 116
Study: 16449106

Group type: EXPERIMENTAL
Intervention: Foley with extra-amniotic saline infusion
Number of subjects: 140

Group type: COMPARATOR
Intervention: Foley alone
Number of subjects: 140
Study: 15267006

Group type: EXPERIMENTAL
Intervention: Volume expansion with 300 ml saline during CM administration
Number of subjects: 39

Group type: COMPARATOR
Intervention: Intravenous administration of at least 2,000 ml saline within 12 h before and after CM application
Number of subjects: 39
Study: 11687322

Group type: EXPERIMENTAL
Intervention: Course in psychosocial oncology for nurses, consisting of four 3-hour weekly lessons and follow-up discussions at termination and 5 months later.
Number of subjects: 6
Study: 9224082

Group type: EXPERIMENTAL
Intervention: Aciclovir suspension 15 mg/kg five times a day for seven days
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 8463201

Group type: EXPERIMENTAL
Intervention: Children with autism
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Children with RDLD
Number of subjects: 3

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 3
Study: 3606933

Group type: EXPERIMENTAL
Intervention: Food intake (standard breakfast)
Number of subjects: 24
Study: 29134614

Group type: EXPERIMENTAL
Intervention: Intradiaytic exercise (20 minutes)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control hemodialysis session
Number of subjects: 9
Study: 26947328

Group type: EXPERIMENTAL
Intervention: Metformin (250 mg daily)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 24749642

Group type: EXPERIMENTAL
Intervention: Reappraising arousal as beneficial
Number of subjects: 0

Group type: COMPARATOR
Intervention: No instructions (control)
Number of subjects: 0
Study: 23927603

Group type: EXPERIMENTAL
Intervention: CKD-specific computer decision support (CDS) plus practice facilitation (TRANSLATE model)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: CKD-specific computer decision support (CDS) alone
Number of subjects: 2000
Study: 20589368

Group type: EXPERIMENTAL
Intervention: Weekly bisphosphonates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Daily bisphosphonates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monthly bisphosphonates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Annual zoledronic acid infusions
Number of subjects: 0
Study: 19430310

Group type: EXPERIMENTAL
Intervention: Torasemide (8 mg/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Azosemide (60 mg/d)
Number of subjects: 30
Study: 17056786

Group type: EXPERIMENTAL
Intervention: Simulation-based training for laparoscopic suturing and knot-tying
Number of subjects: 11

Group type: COMPARATOR
Intervention: Senior-level surgery residents performing laparoscopic suturing and knot-tying
Number of subjects: 11
Study: 12783427

Group type: EXPERIMENTAL
Intervention: Continuous transcranial 2 MHz Doppler ultrasound (C-US) monitoring over 1 hour
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no ultrasound)
Number of subjects: 25
Study: 10961522

Group type: EXPERIMENTAL
Intervention: gl-30 (glucose ingestion 30 min prior)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: gl-60 (glucose ingestion 60 min prior)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: gl-90 (glucose ingestion 90 min prior)
Number of subjects: 8

Group type: COMPARATOR
Intervention: pl-60 (placebo 60 min prior)
Number of subjects: 8
Study: 9322191

Group type: EXPERIMENTAL
Intervention: Olive oil (40 g of fat/m2 body surface area)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Milk fat (40 g of fat/m2 body surface area)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Safflower oil (40 g of fat/m2 body surface area)
Number of subjects: 8
Study: 8358459

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia
Number of subjects: 83

Group type: COMPARATOR
Intervention: Intramuscular injections
Number of subjects: 83
Study: 3065738

Group type: EXPERIMENTAL
Intervention: Chlorambucil (0.4 mg/kg orally days 5 and 6) plus prednisone (60 mg/m2 orally days 1 to 4) every 2 weeks (CL + PDN)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Cyclophosphamide (160 mg/m2 orally days 1 to 4), melphalan (6 mg/m2 orally days 1 to 4), and prednisone (60 mg/m2 orally days 1 to 4) every 3 weeks for 10 months (CMP)
Number of subjects: 96
Study: 28887274

Group type: EXPERIMENTAL
Intervention: Qualitative MRI measure for muscle fat infiltration (MFI)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: WAD participants (mild or moderate and severe)
Number of subjects: 62
Study: 27693004

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg)
Number of subjects: 990

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: Statin therapy (general)
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: Combination of clinical risk profile and CAC score
Number of subjects: 990
Study: 25650378

Group type: EXPERIMENTAL
Intervention: Behavioral secondhand smoke (SHS) reduction program
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard care control group
Number of subjects: 71
Study: 23625945

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 2737

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2737
Study: 21114352

Group type: EXPERIMENTAL
Intervention: Interacting with a prejudiced partner (compared to unprejudiced partner) for members of stigmatized groups who believe the status system is fair.
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Interacting with a prejudiced partner (compared to unprejudiced partner) for members of stigmatized groups who believe the status system is unfair.
Number of subjects: 2
Study: 19039466

Group type: EXPERIMENTAL
Intervention: 14% duty cycle (n=21)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 67% duty cycle (n=17)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Both groups (14% and 67% duty cycles)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Both cycles
Number of subjects: 32
Study: 16635922

Group type: EXPERIMENTAL
Intervention: Oligo-antigenic diet
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: DBPFC challenge
Number of subjects: 4

Group type: COMPARATOR
Intervention: Food hypersensitivity
Number of subjects: 4

Group type: COMPARATOR
Intervention: Histological examination
Number of subjects: 4
Study: 12913325

Group type: EXPERIMENTAL
Intervention: Blood glucose regulation (metabolic regulation of diabetes)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (age-matched, no specific intervention mentioned)
Number of subjects: 40
Study: 10331109

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg daily) with pindolol (7.5 to 10 mg daily)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Fluoxetine (20 mg daily) with placebo
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Pindolol treatment
Number of subjects: 86
Study: 8759902

Group type: EXPERIMENTAL
Intervention: Cryosupernatant
Number of subjects: 58

Group type: COMPARATOR
Intervention: Fresh Frozen Plasma (FFP)
Number of subjects: 58
Study: 1884932

Group type: EXPERIMENTAL
Intervention: Cytology brush and extended‐tip wooden spatula
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Moistened cotton swab and extended‐tip wooden spatula
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Extended‐tip wooden spatula and Ayre blunt spatula
Number of subjects: 96

Group type: COMPARATOR
Intervention: Strict adherence to a collection protocol
Number of subjects: 96

Group type: COMPARATOR
Intervention: Education on tools and collection methods
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Widespread use of the cytology brush post-study
Number of subjects: 96
Study: 6754923

Group type: EXPERIMENTAL
Intervention: Electromyography biofeedback relaxation training
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Skin-conductance biofeedback relaxation training
Number of subjects: 3

Group type: COMPARATOR
Intervention: Normal antenatal classes
Number of subjects: 3
Study: 31093618

Group type: EXPERIMENTAL
Intervention: Venus Bulk Fill (flowable bulk-fill composite)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Dyract eXtra (compomer)
Number of subjects: 32
Study: 28419068

Group type: EXPERIMENTAL
Intervention: TX‐004HR 4, 10, and 25 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25384338

Group type: EXPERIMENTAL
Intervention: lenalidomide
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: marimastat
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: ATN-224
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: imatinib
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: nonhormonal therapy
Number of subjects: 146
Study: 23642343

Group type: EXPERIMENTAL
Intervention: Heparins (unfractionated heparin, heparinoids, or low-molecular-weight heparin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin or placebo
Number of subjects: 0
Study: 21396310

Group type: COMPARATOR
Intervention: Standard laparoscopic instruments and port position
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: SILS with angulated instruments
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: SILS with straight instruments
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: SILS (both angulated and straight instruments)
Number of subjects: 14
Study: 19799788

Group type: EXPERIMENTAL
Intervention: Early enteral feeding regimen (commencing milk feeds on day 2 after birth)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Late enteral feeding regimen (commencing milk feeds on day 6 after birth)
Number of subjects: 400
Study: 19759996

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE) 3 times per week for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance exercise (RE) 3 times per week for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care control (CON)
Number of subjects: 0
Study: 15179231

Group type: EXPERIMENTAL
Intervention: Protocol-driven ventilator weaning
Number of subjects: 0
Study: 11323369

Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg/kg with ondansetron 0.1 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tramadol 1 mg/kg with placebo
Number of subjects: 0
Study: 9338667

Group type: EXPERIMENTAL
Intervention: Topical 2.0% dorzolamide hydrochloride
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Oral acetazolamide (125 mg)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Dorzolamide and Acetazolamide (combined comparison)
Number of subjects: 210
Study: 7894258

Group type: EXPERIMENTAL
Intervention: Carbamazepine for a mean of 30.9 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2966552

Group type: EXPERIMENTAL
Intervention: Low-dose isradipine (0.007 mg/kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-dose isradipine (0.015 mg/kg)
Number of subjects: 16
Study: 29929387

Group type: EXPERIMENTAL
Intervention: Feigning condition; PAI malingering indicators using Negative Impression (NIM) and Negative Distortion (NDS) scales
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Defensive condition; Defensive (DEF) index
Number of subjects: 0
Study: 29580796

Group type: EXPERIMENTAL
Intervention: Levosimendan (0.025‐0.2 μg/kg/min)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 90
Study: 28785879

Group type: EXPERIMENTAL
Intervention: Doravirine 1200 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 45
Study: 26678642

Group type: EXPERIMENTAL
Intervention: Multimodal approach to improving intensity of follow-up visits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early follow-up within 4 weeks of an elevated reading
Number of subjects: 0
Study: 23679917

Group type: EXPERIMENTAL
Intervention: Intervention Arms of the SEYLE project (specific interventions not detailed in the abstract)
Number of subjects: 12395

Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory, Second Edition (BDI‐II)
Number of subjects: 12395

Group type: EXPERIMENTAL
Intervention: Zung Self‐Rating Anxiety Scale (Z‐SAS)
Number of subjects: 12395

Group type: EXPERIMENTAL
Intervention: Strengths and Difficulties Questionnaire (SDQ)
Number of subjects: 12395

Group type: EXPERIMENTAL
Intervention: World Health Organization Well‐Being Scale (WHO‐5)
Number of subjects: 12395
Study: 21214623

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural intervention with Tai Chi
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 18708408

Group type: EXPERIMENTAL
Intervention: Plasma B(6) (pyridoxal 5'-phosphate)
Number of subjects: 1084

Group type: EXPERIMENTAL
Intervention: Plasma B(2) (riboflavin)
Number of subjects: 1084

Group type: EXPERIMENTAL
Intervention: Plasma B(12)
Number of subjects: 1084

Group type: EXPERIMENTAL
Intervention: Dietary intake of vitamin B(2) and B(6)
Number of subjects: 1084
Study: 17068304

Group type: EXPERIMENTAL
Intervention: NXY-059
Number of subjects: 1722

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1722
Study: 12610241

Group type: EXPERIMENTAL
Intervention: Willingness to pay for depression treatment at baseline
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Willingness to pay for depression treatment at six-month follow-up
Number of subjects: 615
Study: 10638900

Group type: EXPERIMENTAL
Intervention: Epidural blockade with bupivacaine 0.25%
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dextrose infusion (4 mg x kg(‐1) x min(‐1))
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (no epidural blockade)
Number of subjects: 6
Study: 8866920

Group type: EXPERIMENTAL
Intervention: 200 mg didanosine as a single agent
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 mg trimethoprim + 1000 mg sulphamethoxazole
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 mg trimethoprim + 200 mg didanosine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1000 mg sulphamethoxazole + 200 mg didanosine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 mg trimethoprim + 1000 mg sulphamethoxazole + 200 mg didanosine
Number of subjects: 10
Study: 1996756

Group type: EXPERIMENTAL
Intervention: oesophageal heat exchanger
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: overhead radiant heater
Number of subjects: 30

Group type: COMPARATOR
Intervention: no active rewarming
Number of subjects: 30
Study: 6504632

Group type: EXPERIMENTAL
Intervention: Intramuscular vitamin E administration (100 mg/kg/d for at least 8 weeks, first dose within 8 hours of life)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 134
Study: 30853068

Group type: EXPERIMENTAL
Intervention: Bass brushing method (n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care (n=15)
Number of subjects: 30
Study: 29859706

Group type: EXPERIMENTAL
Intervention: Bilateral sonolysis
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 144
Study: 27794259

Group type: EXPERIMENTAL
Intervention: Fluid Immersion Simulation mattress (high immersion setting)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fluid Immersion Simulation mattress (medium immersion setting)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fluid Immersion Simulation mattress (low immersion setting)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Lateral tilt posture
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Supine posture
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: High-sitting posture
Number of subjects: 17
Study: 24623104

Group type: EXPERIMENTAL
Intervention: GC1113 intravenous 3-5 μg/kg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: GC1113 subcutaneous 1-8 μg/kg
Number of subjects: 96

Group type: COMPARATOR
Intervention: Darbepoetin alfa 30 μg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: GC1113 intravenous 0.3-5 μg/kg
Number of subjects: 96
Study: 22239992

Group type: COMPARATOR
Intervention: IL10G short G20 allele
Number of subjects: 82

Group type: COMPARATOR
Intervention: Combined haplotypes cH1/cH8 (short G20 + R13 alleles)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Levels of Abs to PF4 in Ab(pos) patients
Number of subjects: 82
Study: 20103509

Group type: EXPERIMENTAL
Intervention: Posthorax support vest (group B)
Number of subjects: 1560

Group type: COMPARATOR
Intervention: Flexible dressing (group A)
Number of subjects: 1560
Study: 18341417

Group type: EXPERIMENTAL
Intervention: Active laser treatment (810-nm Ga-Al-As laser, 60 mW, 1.8 J per point, 14.4 J per session, 12 sessions over 8 weeks)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Active laser treatment
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 63
Study: 15735445

Group type: EXPERIMENTAL
Intervention: Single intrapartum nevirapine (NVP) dose
Number of subjects: 43